GELM-9

hTERT-Immortalised Human Myofibroblast Cell Line

Biogut Technologies Inc is a leading biotech company specializing in innovative solutions for fibrosis research. One of our offerings includes an hTERT immortalized myofibroblast cell line, (termed GELM-9) which can provide researchers globally with a reliable tool to study fibrosis mechanisms and develop novel diagnostics and therapeutics.

This cell line, derived from a healthy human gut biopsy, offers exceptional stability and longevity due to its immortalization with hTERT, ensuring consistent results over extended periods of research. By utilizing this advanced model, scientists can investigate the underlying pathways involved in fibrosis progression and test potential drug candidates with greater accuracy and efficiency.

*Fluorescent image of GELM-9 cells

Biogut's hTERT immortalized myofibroblast cell line opens new avenues for understanding fibrotic diseases, such as inflammatory bowel fibrosis, pulmonary fibrosis, liver cirrhosis, and cardiac fibrosis.

Our commitment to empowering researchers with cutting-edge tools reflects our dedication to accelerating the development of effective diagnostic tools and therapeutic interventions for fibrosis-related conditions.

Please send us an email at info@biogut.tech for any enquiries on the cell line.